NCT07192029

Brief Summary

To investigate whether using balloon guide catheter with flow arrest during mechanical thrombectomy, compared to non-flow arrest, improves the rate of first pass expanded Thrombolysis in Cerebral Infarction score (eTICI 2c-3) reperfusion for acute ischemic stroke due to internal carotid artery occlusion

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
364

participants targeted

Target at P75+ for not_applicable stroke

Timeline
8mo left

Started Oct 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Oct 2025Dec 2026

First Submitted

Initial submission to the registry

September 8, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 25, 2025

Completed
17 days until next milestone

Study Start

First participant enrolled

October 12, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

November 17, 2025

Status Verified

November 1, 2025

Enrollment Period

11 months

First QC Date

September 8, 2025

Last Update Submit

November 13, 2025

Conditions

Keywords

Balloon Guide CatheterThrombectomyInternal Carotid Artery

Outcome Measures

Primary Outcomes (1)

  • Rate of first-pass reperfusion defined as eTICI 2c-3 reperfusion

    Perioperative

Secondary Outcomes (10)

  • Good outcome proportion, defined as mRS score 0-2

    90 days (±7 days) post-procedure

  • Ordinal Distribution of mRS Scores (mRS Shift analysis)

    90 days (±7 days)

  • Change in stroke severity (NIHSS score)

    7 days or discharge (whichever occurs first);

  • Technical success rate

    Perioperative

  • Final angiographic reperfusion results (eTICI ≥2b, eTICI ≥2c, eTICI 3)

    Perioperative

  • +5 more secondary outcomes

Study Arms (2)

The experimental group

EXPERIMENTAL
Procedure: Balloon guide catheter combined with conventional thrombectomy treatment

The control group

SHAM COMPARATOR
Procedure: Standard guide catheter or neurovascular sheath combined with conventional thrombectomy treatment

Interventions

The experimental group will use balloon guide catheter combined with conventional thrombectomy treatment.

The experimental group

use standard guide catheter or neurovascular sheath combined with conventional thrombectomy treatment

The control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years;
  • Clinical diagnosis of acute ischemic stroke with internal carotid artery occlusion confirmed by imaging (CTA/MRA/DSA), including isolated intracranial internal carotid artery (I-type), internal carotid artery intracranial segment involving middle cerebral artery (L-type), or internal carotid artery intracranial segment involving middle and anterior cerebral arteries (T-type) (including tandem embolic occlusions of the internal carotid artery C1 or common carotid artery);
  • Baseline NIHSS≥6, and meeting local guidelines for mechanical thrombectomy;
  • Time from onset or last known normal to randomization within 24 hours and proceeding to mechanical thrombectomy;
  • Signed informed consent (or by legal representative).

You may not qualify if:

  • Pre-stroke mRS score \>2
  • Intracranial hemorrhage shown on imaging;
  • Known or suspected internal carotid artery occlusion caused by dissection or atherosclerosis;
  • Vascular tortuosity preventing the use of balloon guide catheter;
  • Prior stent implantation in the target vessel that would impede the use or removal of mechanical thrombectomy devices;
  • Any other circumstances impeding mechanical thrombectomy implementation;
  • Acute occlusion of multiple vascular territories in bilateral anterior circulation or in both the anterior and posterior circulations confirmed by CTA/MRA;
  • Pregnant subjects;
  • Subjects allergic to contrast agents;
  • Subjects refusing to cooperate or unable to tolerate interventional procedures;
  • Subjects whose expected lifetime are less than 90 days;
  • Midline shift or herniation with ventricular mass effect;
  • Subjects deemed unable to participate in follow-up by investigators;
  • Other situations deemed unsuitable for balloon guide catheter use by investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

RECRUITING

Zhangzhou Municipal Hospital

Zhangzhou, Fujian, China

RECRUITING

Xuanwu Hospital, Capital Medical University.

Beijing, 100053, China

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2025

First Posted

September 25, 2025

Study Start

October 12, 2025

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

November 17, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations